Skip to main content

HomeResearchDavunetide

CategoryCognitive
SafetyLow Risk
StatusResearch Only

Davunetide

NAP · NAPVSIPQ · AL-108 · ADNP peptide

CategoryCognitive
Half-life
Routeintranasal, subcutaneous
RiskLow Risk
ProvidersNone listed

About Davunetide

Stabilizes microtubules by interacting with tubulin and microtubule-associated proteins. Activates SIRT1, reduces amyloid-β toxicity, and enhances synaptic plasticity. Protects against tau hyperphosphorylation.

An 8-amino acid neuroprotective peptide derived from Activity-Dependent Neuroprotective Protein (ADNP). Among the most potent neuroprotective agents identified in preclinical models. Studied for Alzheimer's disease, schizophrenia, and traumatic brain injury.

Research Areas

neuroprotectiontau stabilizationcognitive enhancementmemory

Regulatory & Evidence

Risk Profile

Low Risk

Generally considered lower risk in research contexts. Risk profile varies by individual — review contraindications before use.

Regulatory Status

Availability Status
Research Only

Regulatory status reflects publicly available information and may change. This is not legal or medical advice.

Safety Notes

Low Risk

Generally considered lower risk in research contexts. Individual response varies — review all considerations before use.

Reported contraindications & considerations

Pregnant Or Nursing

Consult a qualified healthcare professional before making any health decisions. This information is educational only and does not constitute medical advice.

Where to Find Davunetide

Coverage expanding

No verified providers currently list Davunetide. Get notified when one does, or explore providers carrying similar peptides in the Cognitive category.

Frequently Asked Questions — Davunetide

An 8-amino acid neuroprotective peptide derived from Activity-Dependent Neuroprotective Protein (ADNP). Among the most potent neuroprotective agents identified in preclinical models.

neuroprotection, tau stabilization, cognitive enhancement, memory, synaptic plasticity.

Newsletter

The Peptide Research Digest

New providers, emerging stacks, and research developments — weekly.

No spam. Unsubscribe anytime. Privacy policy.